Literature DB >> 35382144

Are diffuse and limited juvenile systemic sclerosis different in clinical presentation? Clinical characteristics of a juvenile systemic sclerosis cohort.

Ivan Foeldvari1, Jens Klotsche2, Kathryn S Torok3, Ozgur Kasapcopur4, Amra Adrovic4, Valda Stanevicha5, Maria Teresa Terreri6, Ekaterina Alexeeva7, Maria Katsicas8, Rolando Cimaz9, Mikhail Kostik10, Thomas Lehman11, Walter-Alberto Sifuentes-Giraldo12, Vanessa Smith13, Flavio Sztajnbok14, Tadej Avcin15, Maria Jose Santos16, Monika Moll17, Dana Nemcova18, Cristina Battagliotti19, Despina Eleftheriou20, Mahesh Janarthanan21, Tilmann Kallinich22, Jordi Anton23, Kirsten Minden2,22, Susan Nielsen24, Yosef Uziel25, Nicola Helmus1.   

Abstract

Introduction: Juvenile systemic sclerosis is an orphan disease. Currently, the majority of juvenile systemic sclerosis cohort studies are retrospective in design without standardized assessment. This study was conducted prospectively to investigate the difference in manifestations of limited cutaneous juvenile systemic sclerosis and diffuse cutaneous juvenile systemic sclerosis subtypes. An additional aim was to compare these data to other juvenile systemic sclerosis cohorts and a large adult systemic sclerosis cohort.
Methods: Patients fulfilling the Paediatric Rheumatology European Society juvenile systemic sclerosis classification criteria were included. Clinical characteristics and patient-related outcomes were assessed.
Results: In all, 88 patients with a mean disease duration of 3.5 years were enrolled, 72.5% with diffuse cutaneous juvenile systemic sclerosis with a mean modified Rodnan Skin score of 18 and 27.5% with limited cutaneous juvenile systemic sclerosis with mean modified Rodnan Skin score of 9. The mean age at the onset of Raynaud's and first non-Raynaud's symptoms was similar in both groups, approximately 9 and 10.5 years. Active digital tip ulcerations were present in 29% diffuse cutaneous juvenile systemic sclerosis and none in the limited cutaneous juvenile systemic sclerosis subjects (p = 0.005). Of those with cardiopulmonary testing, 3% of diffuse cutaneous juvenile systemic sclerosis and 23% of limited cutaneous juvenile systemic sclerosis group had cardiac involvement (p = 0.015), and 41% diffuse cutaneous juvenile systemic sclerosis and 22% of the limited cutaneous juvenile systemic sclerosis group had pulmonary involvement (p = 0.009). Physician global disease damage assessment was higher in the diffuse cutaneous juvenile systemic sclerosis group compared to the limited cutaneous juvenile systemic sclerosis group: 35 and 15 (p = 0.021). Discussion: The majority of this international juvenile systemic sclerosis cohort had diffuse cutaneous juvenile systemic sclerosis (72.5%) with more frequent vascular and pulmonary involvement compared to the limited cutaneous group, who had increased cardiac involvement. Our cohort reflects prior findings of published juvenile systemic sclerosis cohorts and emphasizes a difference in the presentation compared to adult-onset systemic sclerosis.
© The Author(s) 2018.

Entities:  

Keywords:  Juvenile scleroderma; diffuse cutaneous subset; juvenile systemic sclerosis; limited cutaneous subset; organ involvement; patient-related outcomes

Year:  2018        PMID: 35382144      PMCID: PMC8922583          DOI: 10.1177/2397198318790494

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  24 in total

1.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

2.  Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey.

Authors:  I Foeldvari; M Zhavania; N Birdi; R J Cuttica; S H de Oliveira; P B Dent; R Elborgh; F Falcini; G Ganser; H Girschick; R Häfner; R Joos; W Kuis; P Pelkonen; A M Prieur; K Rostropowicz-Denisiewicz; R Russo; A Savolainen; A Siamopoulou-Mayridou; F Zulian
Journal:  Rheumatology (Oxford)       Date:  2000-05       Impact factor: 7.580

3.  Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database.

Authors:  Giorgia Martini; Ivan Foeldvari; Ricardo Russo; Ruben Cuttica; Anne Eberhard; Angelo Ravelli; Thomas J A Lehman; Sheila Knupp Feitosa de Oliveira; Gordana Susic; Galina Lyskina; Dana Nemcova; Robert Sundel; Fernanda Falcini; Herman Girschick; Ana Paula Lotito; Antonella Buoncompagni; Flavio Sztajnbok; Sulaiman M Al-Mayouf; Ilonka Orbàn; Clodoveo Ferri; Balu H Athreya; Patricia Woo; Francesco Zulian
Journal:  Arthritis Rheum       Date:  2006-12

4.  Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease.

Authors:  Kenneth Scalapino; Thaschawee Arkachaisri; Mary Lucas; Noreen Fertig; David J Helfrich; Aldo V Londino; Virginia D Steen; Thomas A Medsger
Journal:  J Rheumatol       Date:  2006-04-01       Impact factor: 4.666

Review 5.  Juvenile systemic sclerosis: report of three cases and review of Japanese published work.

Authors:  Kumi Aoyama; Yayoi Nagai; Yukie Endo; Osamu Ishikawa
Journal:  J Dermatol       Date:  2007-09       Impact factor: 4.005

6.  Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry.

Authors:  Angela Byun Robinson; Mark F Hoeltzel; Dawn M Wahezi; Mara L Becker; Elizabeth A Kessler; Heinrike Schmeling; Ruy Carrasco; Adam M Huber; Brian M Feldman; Ann M Reed
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-03       Impact factor: 4.794

Review 7.  Scleroderma renal crisis.

Authors:  Luc Mouthon; Guillaume Bussone; Alice Berezné; Laure-Hélène Noël; Loïc Guillevin
Journal:  J Rheumatol       Date:  2014-05-15       Impact factor: 4.666

8.  Juvenile onset systemic sclerosis: a single center experience of 23 cases from Asia.

Authors:  Ramnath Misra; Gurmeet Singh; Parshant Aggarwal; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2006-12-19       Impact factor: 3.650

9.  Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort.

Authors:  Yannick Allanore; Christopher P Denton; Thomas Krieg; Peter Cornelisse; Daniel Rosenberg; Barbara Schwierin; Marco Matucci-Cerinic
Journal:  Ann Rheum Dis       Date:  2016-06-27       Impact factor: 19.103

10.  Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes.

Authors:  Christine Peoples; Thomas A Medsger; Mary Lucas; Bedda L Rosario; Carol A Feghali-Bostwick
Journal:  J Scleroderma Relat Disord       Date:  2016-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.